Ultrasound-based follow-up does not increase survival in early-stage melanoma patients: A comparative cohort study
- 1 November 2017
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 85, 59-66
- https://doi.org/10.1016/j.ejca.2017.07.051
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients—Results after 1 YearAnnals of Surgical Oncology, 2016
- Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort studyJournal of the American Academy of Dermatology, 2016
- US melanoma prevalence has doubled over past 30 yearsBMJ, 2015
- Long-term Follow-up for Melanoma PatientsSurgical Oncology Clinics of North America, 2015
- To what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?International Journal of Clinical Practice, 2014
- Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive reviewBritish Journal of Dermatology, 2014
- Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015Journal of the European Academy of Dermatology and Venereology, 2013
- MelanomaThe New England Journal of Medicine, 2006
- Follow-up in patients with localised primary cutaneous melanomaThe Lancet Oncology, 2005
- Prospective Evaluation of a Follow-Up Schedule in Cutaneous Melanoma Patients: Recommendations for an Effective Follow-Up StrategyJournal of Clinical Oncology, 2003